A case–case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants

Author:

Wu Dan1,Ye Ying2,Tang Lin1,Wang Ai-Bin3,Zhang Rui4,Qian Zhao-Hui5,Wang Fu-Zhen1,Zheng Hui1,Huang Chang67,Lv Xiao-Ya8,Wang Hai-Feng2,Zhang Yan-Yang2,Pan Jing-Jing2,Li Ya-Fei2,Lu Ming-Xia2,Wang Chang-Shuang2,Ma Ya-Ting2,An Zhi-Jie1,Rodewald Lance Everett1,Yin Zun-Dong1,Wang Xuan-Yi910ORCID,Wu Zhi-Yin8,Shao Yi-Ming11

Affiliation:

1. National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China

2. Henan Provincial Disease Control and Prevention, People’s Republic of China, Henan

3. Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China

4. National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

5. NHC Key laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

6. Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China

7. Nanning Center for Disease Control and Prevention, Guangxi, People's Republic of China

8. Development Center for Medicine and Science &Technology, National Health Commission, People’s Republic of China, Beijing

9. Key Laboratory of Medical Molecular Virology of MoE & MoH, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, People’s Republic of China

10. Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China

11. State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China

Funder

Chinese Center for Disease Control and Prevention

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3